View Financial HealthHydrapres 배당 및 자사주 매입배당 기준 점검 0/6Hydrapres 배당금을 지급한 기록이 없습니다.핵심 정보0%배당 수익률-32.8%자사주 매입 수익률총 주주 수익률-32.8%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향0%최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Jun 03Hydrapres S.A., Annual General Meeting, Jun 30, 2026Hydrapres S.A., Annual General Meeting, Jun 30, 2026, at 10:00 Central European Standard Time.Reported Earnings • May 21First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: zł8.04m (up 16% from 1Q 2025). Net loss: zł1.17m (loss narrowed 19% from 1Q 2025).New Risk • Feb 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Polish stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 55% per year over the past 5 years. Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Market cap is less than US$10m (zł29.6m market cap, or US$8.27m).공시 • Feb 10Hydrapres S.A. to Report Q4, 2025 Results on Feb 13, 2026Hydrapres S.A. announced that they will report Q4, 2025 results on Feb 13, 2026분석 기사 • Dec 30Here's Why Hydrapres (WSE:HPS) Can Afford Some DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...공시 • Nov 13Hydrapres S.A. to Report Q3, 2025 Results on Nov 14, 2025Hydrapres S.A. announced that they will report Q3, 2025 results on Nov 14, 2025New Risk • Oct 05New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 47% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł1.9m free cash flow). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Market cap is less than US$10m (zł27.3m market cap, or US$7.53m). Minor Risk Share price has been volatile over the past 3 months (8.0% average weekly change).Reported Earnings • Aug 19Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: zł7.77m (down 8.2% from 2Q 2024). Net loss: zł1.15m (loss narrowed 38% from 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.분석 기사 • Jun 19Hydrapres (WSE:HPS) Has Debt But No Earnings; Should You Worry?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Aug 19Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł8.46m (down 14% from 2Q 2023). Net loss: zł1.86m (loss widened 22% from 2Q 2023).공시 • Jun 05Hydrapres S.A., Annual General Meeting, Jun 28, 2024Hydrapres S.A., Annual General Meeting, Jun 28, 2024.New Risk • May 20New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -zł3.4m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł3.4m free cash flow). Earnings have declined by 81% per year over the past 5 years. Market cap is less than US$10m (zł16.2m market cap, or US$4.13m).Reported Earnings • Feb 16Full year 2023 earnings released: zł0.16 loss per share (vs zł0.03 loss in FY 2022)Full year 2023 results: zł0.16 loss per share (further deteriorated from zł0.03 loss in FY 2022). Revenue: zł37.7m (down 13% from FY 2022). Net loss: zł5.72m (loss widened 429% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 131 percentage points per year, which is a significant difference in performance.공시 • Jan 17+ 4 more updatesHydrapres S.A. to Report Q3, 2024 Results on Nov 14, 2024Hydrapres S.A. announced that they will report Q3, 2024 results on Nov 14, 2024Reported Earnings • Nov 19Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: zł9.08m (down 22% from 3Q 2022). Net loss: zł1.65m (loss widened zł1.57m from 3Q 2022).Reported Earnings • Aug 14Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł9.84m (down 11% from 2Q 2022). Net loss: zł1.53m (down 467% from profit in 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 111 percentage points per year, which is a significant difference in performance.공시 • Jun 04Hydrapres S.A., Annual General Meeting, Jun 28, 2023Hydrapres S.A., Annual General Meeting, Jun 28, 2023, at 11:00 Central European Standard Time.Reported Earnings • May 21First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: zł10.6m (down 5.1% from 1Q 2022). Net loss: zł1.09m (down zł1.19m from profit in 1Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.Reported Earnings • Feb 18Full year 2022 earnings released: zł0.03 loss per share (vs zł0.008 profit in FY 2021)Full year 2022 results: zł0.03 loss per share (down from zł0.008 profit in FY 2021). Revenue: zł43.5m (up 34% from FY 2021). Net loss: zł1.08m (down 479% from profit in FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance.공시 • Jan 20+ 3 more updatesHydrapres S.A. to Report Fiscal Year 2022 Results on May 29, 2023Hydrapres S.A. announced that they will report fiscal year 2022 results on May 29, 2023Reported Earnings • Aug 19Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł11.0m (up 44% from 2Q 2021). Net income: zł417.4k (down 42% from 2Q 2021). Profit margin: 3.8% (down from 9.4% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 13% per year, which means it is tracking significantly ahead of earnings growth.공시 • May 27Hydrapres S.A., Annual General Meeting, Jun 24, 2022Hydrapres S.A., Annual General Meeting, Jun 24, 2022, at 12:00 Central European Standard Time.Reported Earnings • Feb 17Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: zł0.01 (up from zł0.007 in FY 2020). Revenue: zł32.6m (up 24% from FY 2020). Net income: zł363.1k (up 42% from FY 2020). Profit margin: 1.1% (up from 1.0% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.공시 • Jan 30+ 4 more updatesHydrapres S.A. to Report Fiscal Year 2021 Results on May 27, 2022Hydrapres S.A. announced that they will report fiscal year 2021 results on May 27, 2022Reported Earnings • Aug 19Second quarter 2021 earnings releasedThe company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: zł7.65m (up 51% from 2Q 2020). Net income: zł716.7k (up zł892.6k from 2Q 2020). Profit margin: 9.4% (up from net loss in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance.Reported Earnings • Feb 17Full year 2020 earnings released: EPS zł0.007 (vs zł0.007 in FY 2019)The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: zł26.4m (down 30% from FY 2019). Net income: zł256.3k (down 4.6% from FY 2019). Profit margin: 1.0% (up from 0.7% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Is New 90 Day High Low • Feb 10New 90-day high: zł0.42The company is up 15% from its price of zł0.36 on 10 November 2020. The Polish market is up 10.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Machinery industry, which is up 33% over the same period.공시 • Jan 16+ 4 more updatesHydrapres S.A. to Report Q3, 2021 Results on Nov 10, 2021Hydrapres S.A. announced that they will report Q3, 2021 results on Nov 10, 2021Is New 90 Day High Low • Jan 07New 90-day high: zł0.40The company is up 6.0% from its price of zł0.37 on 09 October 2020. The Polish market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Machinery industry, which is up 22% over the same period.Is New 90 Day High Low • Oct 02New 90-day low: zł0.32The company is down 13% from its price of zł0.37 on 01 July 2020. The Polish market is down 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Machinery industry, which is up 1.0% over the same period.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 HPS 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: HPS 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Hydrapres 배당 수익률 vs 시장HPS의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (HPS)0%시장 하위 25% (PL)2.8%시장 상위 25% (PL)7.0%업계 평균 (Machinery)2.5%분석가 예측 (HPS) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 HPS 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 HPS 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: HPS Polish 시장에서 주목할만한 배당금을 지급하지 않습니다.주주 현금 배당현금 흐름 범위: HPS 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YPL 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/05 09:53종가2026/06/05 00:00수익2026/03/31연간 수익2024/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Hydrapres S.A.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Jun 03Hydrapres S.A., Annual General Meeting, Jun 30, 2026Hydrapres S.A., Annual General Meeting, Jun 30, 2026, at 10:00 Central European Standard Time.
Reported Earnings • May 21First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: zł8.04m (up 16% from 1Q 2025). Net loss: zł1.17m (loss narrowed 19% from 1Q 2025).
New Risk • Feb 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Polish stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 55% per year over the past 5 years. Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Market cap is less than US$10m (zł29.6m market cap, or US$8.27m).
공시 • Feb 10Hydrapres S.A. to Report Q4, 2025 Results on Feb 13, 2026Hydrapres S.A. announced that they will report Q4, 2025 results on Feb 13, 2026
분석 기사 • Dec 30Here's Why Hydrapres (WSE:HPS) Can Afford Some DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
공시 • Nov 13Hydrapres S.A. to Report Q3, 2025 Results on Nov 14, 2025Hydrapres S.A. announced that they will report Q3, 2025 results on Nov 14, 2025
New Risk • Oct 05New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 47% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł1.9m free cash flow). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Market cap is less than US$10m (zł27.3m market cap, or US$7.53m). Minor Risk Share price has been volatile over the past 3 months (8.0% average weekly change).
Reported Earnings • Aug 19Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: zł7.77m (down 8.2% from 2Q 2024). Net loss: zł1.15m (loss narrowed 38% from 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
분석 기사 • Jun 19Hydrapres (WSE:HPS) Has Debt But No Earnings; Should You Worry?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Aug 19Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł8.46m (down 14% from 2Q 2023). Net loss: zł1.86m (loss widened 22% from 2Q 2023).
공시 • Jun 05Hydrapres S.A., Annual General Meeting, Jun 28, 2024Hydrapres S.A., Annual General Meeting, Jun 28, 2024.
New Risk • May 20New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -zł3.4m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł3.4m free cash flow). Earnings have declined by 81% per year over the past 5 years. Market cap is less than US$10m (zł16.2m market cap, or US$4.13m).
Reported Earnings • Feb 16Full year 2023 earnings released: zł0.16 loss per share (vs zł0.03 loss in FY 2022)Full year 2023 results: zł0.16 loss per share (further deteriorated from zł0.03 loss in FY 2022). Revenue: zł37.7m (down 13% from FY 2022). Net loss: zł5.72m (loss widened 429% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 131 percentage points per year, which is a significant difference in performance.
공시 • Jan 17+ 4 more updatesHydrapres S.A. to Report Q3, 2024 Results on Nov 14, 2024Hydrapres S.A. announced that they will report Q3, 2024 results on Nov 14, 2024
Reported Earnings • Nov 19Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: zł9.08m (down 22% from 3Q 2022). Net loss: zł1.65m (loss widened zł1.57m from 3Q 2022).
Reported Earnings • Aug 14Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł9.84m (down 11% from 2Q 2022). Net loss: zł1.53m (down 467% from profit in 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 111 percentage points per year, which is a significant difference in performance.
공시 • Jun 04Hydrapres S.A., Annual General Meeting, Jun 28, 2023Hydrapres S.A., Annual General Meeting, Jun 28, 2023, at 11:00 Central European Standard Time.
Reported Earnings • May 21First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: zł10.6m (down 5.1% from 1Q 2022). Net loss: zł1.09m (down zł1.19m from profit in 1Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.
Reported Earnings • Feb 18Full year 2022 earnings released: zł0.03 loss per share (vs zł0.008 profit in FY 2021)Full year 2022 results: zł0.03 loss per share (down from zł0.008 profit in FY 2021). Revenue: zł43.5m (up 34% from FY 2021). Net loss: zł1.08m (down 479% from profit in FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance.
공시 • Jan 20+ 3 more updatesHydrapres S.A. to Report Fiscal Year 2022 Results on May 29, 2023Hydrapres S.A. announced that they will report fiscal year 2022 results on May 29, 2023
Reported Earnings • Aug 19Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł11.0m (up 44% from 2Q 2021). Net income: zł417.4k (down 42% from 2Q 2021). Profit margin: 3.8% (down from 9.4% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 13% per year, which means it is tracking significantly ahead of earnings growth.
공시 • May 27Hydrapres S.A., Annual General Meeting, Jun 24, 2022Hydrapres S.A., Annual General Meeting, Jun 24, 2022, at 12:00 Central European Standard Time.
Reported Earnings • Feb 17Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: zł0.01 (up from zł0.007 in FY 2020). Revenue: zł32.6m (up 24% from FY 2020). Net income: zł363.1k (up 42% from FY 2020). Profit margin: 1.1% (up from 1.0% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
공시 • Jan 30+ 4 more updatesHydrapres S.A. to Report Fiscal Year 2021 Results on May 27, 2022Hydrapres S.A. announced that they will report fiscal year 2021 results on May 27, 2022
Reported Earnings • Aug 19Second quarter 2021 earnings releasedThe company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: zł7.65m (up 51% from 2Q 2020). Net income: zł716.7k (up zł892.6k from 2Q 2020). Profit margin: 9.4% (up from net loss in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance.
Reported Earnings • Feb 17Full year 2020 earnings released: EPS zł0.007 (vs zł0.007 in FY 2019)The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: zł26.4m (down 30% from FY 2019). Net income: zł256.3k (down 4.6% from FY 2019). Profit margin: 1.0% (up from 0.7% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Is New 90 Day High Low • Feb 10New 90-day high: zł0.42The company is up 15% from its price of zł0.36 on 10 November 2020. The Polish market is up 10.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Machinery industry, which is up 33% over the same period.
공시 • Jan 16+ 4 more updatesHydrapres S.A. to Report Q3, 2021 Results on Nov 10, 2021Hydrapres S.A. announced that they will report Q3, 2021 results on Nov 10, 2021
Is New 90 Day High Low • Jan 07New 90-day high: zł0.40The company is up 6.0% from its price of zł0.37 on 09 October 2020. The Polish market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Machinery industry, which is up 22% over the same period.
Is New 90 Day High Low • Oct 02New 90-day low: zł0.32The company is down 13% from its price of zł0.37 on 01 July 2020. The Polish market is down 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Machinery industry, which is up 1.0% over the same period.